studies conducted early pandemic including icmr not account neutralizing antibodies neutralizing antibodies stick coronavirus prevent infecting cells studies shown recovered patients not levels neutralizing antibodies scientists believe studies tested plasma recovered patients neutralizing antibodies considered reliable levels potency antibodies differ individuals accounted plasma therapy trials says dr archita mishra researcher singapore immunology network test expensive time consuming dr mishra adds crucial explain discrepancies observed plasma therapy trials worldwide factors like age important concluded sex age severity disease useful identifying covid-19 survivors likely high levels antibodies protect disease effective mitigating hypoxia low blood oxygen reducing hospital stay significant section scientists doctors